Literature DB >> 2450156

DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity.

G Pawelec1, N Fernandez, T Brocker, E M Schneider, H Festenstein, P Wernet.   

Abstract

A set of T cell clones (TCC) isolated from HLA-DR-, Dw-, DQ-matched allogeneic MLCs was found to proliferate autonomously when stimulated with cells carrying a wide range of class I or II specificities. This apparently unrestricted proliferation was relatively weak, and only low levels of IL-2 were present in the supernatants of stimulated cells. Autologous as well as allogeneic PBMC and B lymphoblastoid cell lines (B-LCL) were capable of stimulating such clones, which were also restimulated by suppressive, but not by helper, TCC. Moreover, such clones displayed the unusual property of autostimulation. mAb inhibition experiments suggested that class II- or class II-restricted antigens were involved in stimulation. Thus, certain "broad" mAbs (TU39, SG520) reacting with multiple locus products inhibited activation of these reagents, but none of those reacting more specifically with DR (TU34, TU37, L243, Q2/70, SG157), DQ (TU22, SPV-L3, Leu 10), or DP (B7/21), or mixtures of these mAbs, were able to do so. Evidence from sequential immunoprecipitation experiments suggested that mAb TU39 bound class II-like molecules other than DR, DQ, and DP on TCC and B-LCL, and it is therefore proposed that such putative novel class II-like molecules may carry the stimulating determinants for these autoreactive clones. DY-reactive clones lacked helper activity for B cells but mediated potent suppressive activity on T cell proliferative responses that was not restricted by the HLA type of the responding cells. Suppressive activity was induced in normal PBMC by such clones, as well as by independent suppressive clones, which was also inhibited only by mAb TU39. These findings lead to the proposal that DY-reactive autostimulatory cells may constitute a self-maintaining suppressive circuit, the level of activity of which would be regulated primarily by the availability of IL-2 in the microenvironment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450156      PMCID: PMC2188840          DOI: 10.1084/jem.167.2.243

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC molecules.

Authors:  D D Eckels; A Zeevi; P G Beatty; N Flomenberg; S Goyert; R W Knowles; E Mickelson; G T Nepom; P Parham; G Pawelec
Journal:  Hum Immunol       Date:  1986-01       Impact factor: 2.850

2.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

3.  HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.

Authors:  G Pawelec; E M Schneider; C Müller; P Wernet
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

4.  Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.

Authors:  N K Damle; N Mohagheghpour; G S Kansas; D M Fishwild; E G Engleman
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  An autoreactive T cell clone derived after allostimulation in vitro: evidence for recognition of a polymorphic self major histocompatibility complex class II gene product.

Authors:  A Martin; T H Eiermann; L Tricas; S F Goldmann
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

6.  Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s).

Authors:  N Ohta; A Anichini; N L Reinsmoen; G Strassmann; P Wernet; F H Bach
Journal:  Hum Immunol       Date:  1985-05       Impact factor: 2.850

7.  HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes.

Authors:  H Spits; J Borst; M Giphart; J Coligan; C Terhorst; J E De Vries
Journal:  Eur J Immunol       Date:  1984-04       Impact factor: 5.532

8.  T-cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA molecules.

Authors:  E Qvigstad; T Moen; E Thorsby
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

9.  The isolation and characterization of the human suppressor inducer T cell subset.

Authors:  C Morimoto; N L Letvin; J A Distaso; W R Aldrich; S F Schlossman
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes.

Authors:  J R Lamb; J N Woody; R J Hartzman; D D Eckels
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

View more
  5 in total

1.  A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.

Authors:  N Fernandez; M Kurpisz; M Labeta; J Sachs; G Pawelec
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

2.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.

Authors:  G Pawelec; H Schmidt; E Schneider; H J Bühring; G Ehninger
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.

Authors:  K M Wilson; M O Labeta; G Pawelec; N Fernandez
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

5.  Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.

Authors:  Paul Nghiem; William W Kwok; David M Koelle; Natalie V Longino; Junbao Yang; Jayasri G Iyer; Dafina Ibrani; I-Ting Chow; Kerry J Laing; Victoria L Campbell; Kelly G Paulson; Rima M Kulikauskas; Candice D Church; Eddie A James
Journal:  Cancer Immunol Res       Date:  2019-08-12       Impact factor: 11.151

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.